For example, PD-L1 expression on melanoma cells in pretreatment tumor biopsy samples is reported to correlate with response rate, progression free survival, and overall survival in patients with advanced melanoma treated with anti-PD1 antibodies [55], but these antibodies are also effective for PD-L1-negative patients [57]. The gene discussed is CD274; the disease is melanoma.